publication venue for Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.. 12:-. 2023 Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics.. 11:-. 2022
